Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q3 2016 Earnings
ACAD
+0.86%
4
Aug
Confirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-0.63
-0.55
-0.46
-0.38
Details
Expected EPS
-0.51
Actual EPS
-0.63
Surprise EPS
-0.12
Surprise Percent
+23.53%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.63 per share for Q3 2016.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login